A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Recruiting
Observational Study
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Huashan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study was designed to analyze the efficacy and safety of Paxlovid for the treatment of COVID-19.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants who have a positive SARS-CoV-2 test result;
* Participants who have one or more mild or moderate COVID-19 symptoms.
Exclusion Criteria:
* No specific exclusion criteria in this real world study.
Contacts